This Article Full Text Full Text (PDF) Supplemental Figure and Legend All Versions of this Article: 20/12/3053    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Inoue, T. Articles by Ogawa, O. Search for Related Content PubMed PubMed Citation Articles by Inoue, T. Articles by Ogawa, O.

Requirement of Androgen-Dependent Activation of Protein Kinase C for Androgen-Dependent Cell Proliferation in LNCaP Cells and Its Roles in Transition to Androgen-Independent Cells

Department of Urology (T.I., T.Yo., Y.Sh., T.Ko., T.Ya., T.Se., T.Ka., E.N., O.O.), Kyoto University, Graduate School of Medicine, and Anatomical Center of Kyoto University (Y.T.), Graduate School of Medicine, 54 Kawaharacho, Shogoin Sakyo-ku Kyoto 606-8507, Japan

Address all correspondence and requests for reprints to: Eijiro Nakamura, M.D., Ph.D., Department of Urology, Kyoto University Graduate School of Medicine, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan. E-mail: hap{at}kuhp.kyoto-u.ac.jp.

A cell line that we designed, AILNCaP, proliferated in androgen-depleted medium after emerging from long-term androgen-depleted cultures of an androgen-sensitive prostate cancer cell line, LNCaP. Using this cell line as a model of progression to androgen independence, we demonstrated that the activity of the mammalian target of rapamycin/p70 S6 kinase transduction pathway is down-regulated after androgen depletion in LNCaP, whereas its activation is related to transition of this cell line to androgen-independent proliferation. Kinase activity of protein kinase C is regulated by androgen stimulation in LNCaP cells, whereas it is activated constitutively in AILNCaP cells under androgen-depleted conditions. Treatment with a protein kinase C pseudosubstrate inhibitor reduced p70 S6 kinase activity and cell proliferation in both cell lines. We identified that both protein kinase C and p70 S6 kinase were associated in LNCaP cells and this association was enhanced by the androgen stimulation. We examined the expression of phospho-protein kinase C and phospho-p70 S6 kinase in hormone-naive prostate cancer specimens and found that the expression of both kinases was correlated with each other in those specimens. Significant correlation was observed between the expression of both kinases and Ki67 expression. Most of the prostate cancer cells that survived after prior hormonal treatment also expressed both kinases. This is the first report that shows the significance of this pathway for both androgen-dependent and -independent cell proliferation in prostate cancer. Our data suggest that protein kinase C/mammalian target of rapamycin/S6 kinase pathway plays an important role for the transition of androgen-dependent to androgen-independent prostate cancer cells.

NURSA Molecule Pages Link:

Ligands:   Bicalutamide  |  R1881